Cholesterol

angiotensin I converting enzyme ; Homo sapiens







49 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33790999 Association of laboratory parameters and genetic polymorphisms with ischemic stroke in Chinese Han population. 2021 May 1
2 34421038 Adverse Childhood Experiences and Chronic Disease Risk in the Southern Community Cohort Study. 2021 1
3 32356512 Association of angiotensin-converting enzyme insertion/deletion (ACE I/D) and angiotensinogen (AGT M235T) polymorphisms with the risk of obesity in a Tunisian population. 2020 Apr-Jun 1
4 33363465 MicroRNAs Bioinformatics Analyses Identifying HDAC Pathway as a Putative Target for Existing Anti-COVID-19 Therapeutics. 2020 1
5 31430320 The combination of ACE I/D and ACE2 G8790A polymorphisms revels susceptibility to hypertension: A genetic association study in Brazilian patients. 2019 2
6 26483160 Association of angiotensin-converting enzyme I/D and α-actinin-3 R577X genotypes with metabolic syndrome risk factors in Korean children. 2016 Sep 1
7 27050505 Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? 2016 Jun 1
8 24026142 Anti-hypertensive strategies in patients with MEtabolic parameters, DIabetes mellitus and/or NephropAthy (the M E D I N A study). 2014 Sep 1
9 22227126 The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome. 2012 Mar 15 2
10 22307319 Angiotensin converting enzyme gene polymorphism is associated with severity of coronary artery disease in men with high total cholesterol levels. 2012 May 4
11 21216861 High rate of regression from micro-macroalbuminuria to normoalbuminuria in children and adolescents with type 1 diabetes treated or not with enalapril: the influence of HDL cholesterol. 2011 Feb 1
12 21863747 [Antioxidant enzymes in erythrocytes from hypertension patients receiving lisinopril monotherapy or combined lisinopril plus simvastatin therapy]. 2011 May-Jun 2
13 19456900 Influence of angiotensin-converting enzyme I/D gene polymorphism on clinical and histological correlates of chronic hepatitis C. 2009 Aug 1
14 18516470 Association of urinary 90 kDa angiotensin- converting enzyme with family history of hypertension and endothelial function in normotensive individuals. 2008 May 2
15 17941464 [Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients]. 2007 1
16 16490688 Association between angiotensin-converting enzyme insertion/deletion polymorphism and treatment response in type 2 diabetic patients. 2006 Mar 1
17 17044652 Association of angiotensin converting enzyme gene I/D polymorphism with type 2 diabetes mellitus. 2006 Aug 1
18 17168204 [The relationship between ACE I/D polymorphism and HDL cholesterol]. 2006 Nov 4
19 15759455 [Effects of hyper- and dyslipidemias on activity of angiotensin-converting enzyme (biochemical disturbances in metabolic syndrome)]. 2005 1
20 16078597 [Possibilities of outpatient renoprotective therapy]. 2005 1
21 16415489 Angiotensin converting enzyme (ACE) and HydroxyMethylGlutaryl-CoA (HMG-CoA) reductase inhibitors in the forefront of pharmacology of endothelium. 2005 1
22 15646128 [Lipoproteins of blood serum and the activity of angiotensin-converting enzyme]. 2004 Nov 2
23 12624008 Two loci affect angiotensin I-converting enzyme activity in baboons. 2003 Mar 1
24 12658909 Interaction between angiotensin-converting enzyme genotype and glycaemic control influences lipoprotein levels in type 2 diabetes mellitus. 2003 Jan 31 1
25 11896508 Impact of an ACE inhibitor and calcium antagonist on microalbuminuria and lipid subfractions in type 2 diabetes: a randomised, multi-centre pilot study. 2002 Mar 2
26 12020174 Interaction between aspirin and ACE Inhibitors: resolving discrepancies using a meta-analysis. 2002 1
27 12032106 ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. 2002 Jun 3
28 12898814 Angiotensin-converting enzyme gene insertion/deletion polymorphism in Polish patients with myocardial infarction. 2002 1
29 11575216 [Influence of cardiovascular risk factors on prescribing of antihypertensives]. 2001 Aug 1
30 10642275 Increased chymase activity in internal thoracic artery of patients with hypercholesterolemia. 2000 Jan 1
31 10962519 Association of hypertensive status and its drug treatment with lipid and haemostatic factors in middle-aged men: the PRIME study. 2000 Aug 2
32 11054622 ACE/DD genotype is associated with hemostasis balance disturbances reflecting hypercoagulability and endothelial dysfunction in patients with untreated hypertension. 2000 Nov 1
33 10221351 Antiatherosclerotic effect of alacepril, an angiotensin-converting enzyme inhibitor, in monkeys fed a high-cholesterol diet. 1999 Mar 3
34 10488952 The D allele of the angiotensin-converting enzyme gene contributes towards blood LDL-cholesterol levels and the presence of hypertension. 1999 Aug 1
35 10948701 [Angiotensin converting enzyme gene polymorphism in type 2 diabetes mellitus]. 1999 Aug 1
36 9591757 Angiotensin-1-converting enzyme (ACE) gene polymorphism, plasma ACE levels, and their association with the metabolic syndrome and electrocardiographic coronary artery disease in Pima Indians. 1998 May 1
37 9920000 Interethnic differences in coronary heart disease mortality in 25 populations: association with the angiotensin-converting enzyme DD genotype frequency. 1998 Oct-Dec 1
38 8761013 Angiotensin converting enzyme gene polymorphism and renal artery resistance in patients with insulin dependent diabetes mellitus. 1996 1
39 8866203 Angiotensin converting enzyme polymorphism is associated with severity of coronary heart disease and serum lipids (total cholesterol and triglycerides levels) in Japanese patients. 1996 May 1
40 7479254 [Activity of converting enzyme angiotensin I to angiotensin II (ACE) in patients with diabetes type II]. 1995 Apr 2
41 7752591 Plasma lipids and the progression of nephropathy in diabetes mellitus type II: effect of ACE inhibitors. 1995 Mar 1
42 7773733 Relations between deletion polymorphism of the angiotensin-converting enzyme gene and insulin resistance, glucose intolerance, hyperinsulinemia, and dyslipidemia. 1995 Jun 2
43 7852538 Serum angiotensin-I-converting enzyme activity in women with cardiological syndrome X: relation to blood pressure and lipid and carbohydrate metabolic risk markers for coronary heart disease. 1995 Feb 1
44 8907209 Nutritional, metabolic, and genetic determinants of the progression of coronary heart disease. STARS Group. 1995 1
45 7965277 Angiotensin converting enzyme inhibition and coronary artery disease. 1994 Jul 1
46 8285181 Metabolic effects of converting enzyme inhibitors: focus on the reduction of cholesterol and lipoprotein(a) by fosinopril. 1993 Dec 30 1
47 8355471 Role of elevated lecithin: cholesterol acyltransferase and cholesteryl ester transfer protein activities in abnormal lipoproteins from proteinuric patients. 1993 Jul 1
48 8449471 [Lipid metabolism--effect of cardiac agents and ACE inhibitors. Effects of anti-arrhythmia agents, ACE inhibitors, positive inotropic substance and anti-angina agents]. 1993 Feb 20 1
49 2670218 ACE inhibitors in hypertension: a US perspective. 1989 2